Fig. 3From: Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitorsBET inhibition suppresses MYC and BCL6 protein expression in DHL/THL cells. a, b WT-MYC, SH DHL, and THL harboring DLBCL cell lines were treated with JQ1, I-BET, and OTX, and protein expression was assessed by western blotting. Experiments were repeated three times and a representative western blot image is shownBack to article page